Optical Imaging / Therapy
- Chemical Probes for Imaging of Hydrolases in Cancer and Infectious Diseases
- Matthew Bogyo
- Stanford University School of Medicine, U.S.A.
- Near infrared photoimmunotherapy of cancer
- Hisataka Kobayashi
-
National Cancer Institute, NIH, U.S.A
- Molecular optical imaging probes as Artificial Biomarkers for early diagnosis and optical urinalysis
- Kanyi Pu
- Nanyang Technological University, Singapore
- Therapeutic ln Vivo Synthetic Chemistry
- Katsunori Tanaka
- Tokyo Institute of Technology, Japan
- Live imaging-based identification of cancer specific biomarker enzymatic activities and their therapeutic applications
- Yasuteru Urano
- The University of Tokyo, Japan
- Chemical probes for imaging immune cell function
- Marc Vendrell
- The University of Edinburgh, U.K.
- Porphyrin Nanomedicine for Cancer Imaging and Therapy
- Gang Zheng
- University of Toronto, Canada
Radiopharmaceuticals for Diagnosis and Therapy
- Studies of targeted alpha therapy in Osaka University: development of At-211 labeled radiotherapeutics
- Koichi Fukase
- Osaka University, Japan
- FAP-Ligand in Cancer Disease
- Frederik L. Giesel
- University Hospital Heidelberg, Germany
- Boron Neutron Capture Therapy and Targeted Alpha Therapy:
New Radiotherapy Strategy with LAT1 Molecules and PET
- Jun Hatazawa
- Osaka University, Japan
- Targeted Thorium Conjugates (TTCs) – a new approach in Targeted Alpha Therapies (TAT)
- Hartwig H. Hennekes
- Bayer AG, Germany
- A Pretargeted Approach to Radiotheranostics
- Jason S. Lewis
- Memorial Sloan Kettering Cancer Center, U.S.A
- Targeted and non targeted effects of targeted radionuclide therapy
- Jean-Pierre Pouget
- Institute de Recearch en Cancérologie de Montpellier (Inserm), France
Molecular MRI / Theranostics
- New Insights Towards an Improved Characterization of Tumours
- Silvio Aime
- University of Torino, Italy
- Functional and theranostic contrast agents for MRI
- Ichio Aoki
- National Institutes for Quantum and Radiological Science and Technology, Japan
- Applications of Molecular Imaging to the Development of Anti-Fibrotic Therapies
- Peter Caravan
- Harvard Medical School, U.S.A
- Magnetic Particle Imaging: Engineering, Applications, and Tracers
- Steve Conolly
- University of California Berkeley, U.S.A
- Imaging brain activity with molecular MRI probes
- Alan P. Jasanoff
- Massachusetts Institute of Technology, U.S.A
- Nano-particle based sensitive 19F MRI contrast agent with tunable chemical switches
- Kazuya Kikuchi
- Osaka University, Japan
- MRI of the Changing Brain or
MRI Contrast for Detecting Single Cells
- Alan P. Koretsky
- National Institute of Neurological Disorders and Stroke, NIH, U.S.A
|
